Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


electroCore Stimulates More Promise With Migraine Therapy

Executive Summary

New research published in the Journal of Headache and Pain has demonstrated the potential of electroCore's noninvasive vagal nerve stimulation therapy for reducing menstrual migraine attacks by more than a third.

You may also be interested in...

electroCore Reshuffles Top Execs

Non-invasive neurostimulation specialist electroCore reorganizes top management roles as it embarks on next growth phase.

ElectroCore brings in neurogastroenterologist to lead clinical activities

Electrocore, a company specializing in noninvasive vagal nerve stimulation (VNS), has appointed Dr Nader Youssef as Chief Medical Officer. Nader was previously Executive Director of GI Global Clinical Development and Medical Affairs for NPS Pharmaceuticals, where he was responsible for regulatory and development strategy and helped NPS secure US and EU marketing approvals for gastrointestinal drugs. Prior to NPS, he was at AstraZeneca, where his focus was also on GI pain and motility. His expertise in this area will be beneficial to electroCore as it expands its gammaCore noninvasive VNS platform to new indications within gastroenterology and other fields. gammCore was CE-marked in 2011 for treatment of migraine and cluster headaches.

Smith & Nephew Boosts ENT Portfolio, Acquires Tusker Medical

Smith & Nephew has acquired Tusker Medical for an undisclosed price. The acquisition comes just months after Tusker’s Tula system was approved by the FDA as a breakthrough device.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts